To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients (API), including intermediates, Generic Finished Dosage Forms (FDF), and Contract Research services.
Financial Results:
- Laurus Labs Ltd. reported Total Income for Q4FY23 of ₹ 1,382.61 Crores down from ₹ 1,426.12 Crore year on year, a fall of 3%.
- Total Expenses for Q4FY23 of ₹ 1,235.47 Crores up from ₹ 1,124.41 Crores year on year, a rise of 10%.
- Consolidated Net Profit of ₹ 107.24 Crores, down 54% from ₹ 231.90 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 1.90, down 56% from ₹ 4.28 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,